ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Destination XL Group Inc DXLG Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction LAZ Q1 2026 Earnings Missed EPS Estimates Revenue Not Disclosed Shares Edge Higher RLI Corp Q1 2026 Earnings EPS Surpasses Estimates Shares Dip Slightly IMRX Q1 2026 Earnings EPS Beat Estimates by 183 as Clinical Pipeline Advances Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status